Tim-3 Negatively Mediates Natural Killer Cell Function in LPS-Induced Endotoxic Shock
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tim-3 Negatively Mediates Natural Killer Cell Function in LPS-Induced Endotoxic Shock
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 10, Pages e110585
Publisher
Public Library of Science (PLoS)
Online
2014-10-23
DOI
10.1371/journal.pone.0110585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tim-3 signaling pathway as a novel negative mediator in lipopolysaccharide-induced endotoxic shock
- (2014) Feng Wang et al. HUMAN IMMUNOLOGY
- NK but Not CD1-Restricted NKT Cells Facilitate Systemic Inflammation during Polymicrobial Intra-Abdominal Sepsis
- (2014) Anthony O. Etogo et al. JOURNAL OF IMMUNOLOGY
- Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
- (2014) I. P. da Silva et al. Cancer Immunology Research
- T Cell Ig Mucin-3 Promotes Homeostasis of Sepsis by Negatively Regulating the TLR Response
- (2013) X. Yang et al. JOURNAL OF IMMUNOLOGY
- Increased expression of T cell immunoglobulin- and mucin domain-containing molecule-3 on natural killer cells in atherogenesis
- (2012) Nan Hou et al. ATHEROSCLEROSIS
- Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
- (2012) L. C. Ndhlovu et al. BLOOD
- Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
- (2012) M. K. Gleason et al. BLOOD
- Tumor immunity times out: TIM-3 and HMGB1
- (2012) Daolin Tang et al. NATURE IMMUNOLOGY
- The Pathogenesis of Sepsis
- (2011) Deborah J. Stearns-Kurosawa et al. Annual Review of Pathology-Mechanisms of Disease
- Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes
- (2011) Motoko Kanzaki et al. ENDOCRINOLOGY
- The Role of Natural Killer Cells in Sepsis
- (2011) Laurent Chiche et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Increased Granzyme Levels in Cytotoxic T Lymphocytes Are Associated With Disease Severity in Emergency Department Patients With Severe Sepsis
- (2011) Anthony M. Napoli et al. SHOCK
- HTLV-1 Tax Specific CD8+ T Cells Express Low Levels of Tim-3 in HTLV-1 Infection: Implications for Progression to Neurological Complications
- (2011) Lishomwa C. Ndhlovu et al. PLoS Neglected Tropical Diseases
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The costimulatory role of TIM molecules
- (2009) Roselynn Rodriguez-Manzanet et al. IMMUNOLOGICAL REVIEWS
- Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells
- (2009) L. Golden-Mason et al. JOURNAL OF VIROLOGY
- Relationship between CD107a expression and cytotoxic activity
- (2008) Esin Aktas et al. CELLULAR IMMUNOLOGY
- Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis
- (2008) Masako Seki et al. CLINICAL IMMUNOLOGY
- Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice
- (2008) Atsuya Nobumoto et al. CLINICAL IMMUNOLOGY
- Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
- (2008) R. Brad Jones et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- DEPLETION OF NK CELLS IN A MURINE POLYTRAUMA MODEL IS ASSOCIATED WITH IMPROVED OUTCOME AND A MODULATION OF THE INFLAMMATORY RESPONSE
- (2008) Tanja Barkhausen et al. SHOCK
- Activation of Tim-3–Galectin-9 pathway improves survival of fully allogeneic skin grafts
- (2008) Feng Wang et al. TRANSPLANT IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now